(Note: Scribe Therapeutics, Inc. disclosed the terms for its IPO on July 20, 2026, in an S-1/A filing: 7.15 million shares at a price range of $13.00 to $15.00 to raise $100.1 million, if priced at the $14.00 mid-point of its range. Background: Scribe Therapeutics, Inc. filed its S-1 on July 2, 2026, for its IPO, without disclosing the terms. Estimated proceeds were $75 million, a placeholder figure.)

Industry
Biological Products, (no Disgnostic Substances)

CEO	CFO
-

Employees	Founded
89	2017

Contacts

Address: 1150 Marina Village Parkway Alameda, California 94501

Telephone: (510) 626-8587

Web page: https://www.scribetx.com/

IPO information

Expected Date	7/24/2026
Status	Upcoming
Exchange	NASDAQ
Lockup Period Expiration	.Pro
Quiet Period Expiration	.Pro
Old Price Range	-

Share prices ($)

Shares & Volumes

Shares Initial (MM)	7.2
Shares Revised (MM)	-
Expected offer amount (MM)	$100.1
Realized offer amount(MM)	-

Financial Data (last reporting year)

Market Cap (MM)	$226.55
Revenues (MM)	$36.28
Net Income (Loss) (MM)	$-35.73

Voting

What do you think will happen with the SCTX share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes:

The lead left underwriter: Leerink Partners

IPOs led by the firm	.Pro
Profitability of conducted IPOs ?	.Pro
1st day change ?	.Pro
Change for the first 3 months ?	.Pro

Underwriters
Leerink Partners/Goldman Sachs/Guggenheim Securities/Wells Fargo Securities
CO-Managers

Tweets about $SCTX

Tweets
Tweets volume

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats

Interest over time
Interest by region

Scribe Therapeutics, Inc. (SCTX)

Free full financial research

Buy Bitcoin

Free full financial analysis

Scribe Therapeutics, Inc. (SCTX)

Free full financial research

Buy Bitcoin

Free full financial analysis

IPO Pro-version